Eversana

Founded in 2018 and headquartered in Milwaukee, Eversana operates as a private, revenue-generating services and technology provider for the biopharma sector. The company's core business model is centered on offering an integrated suite of commercial services—including market access, patient support, and compliance—powered by its proprietary technology platforms. It addresses the critical need for efficient and effective product commercialization in an increasingly complex and digital healthcare environment. Eversana aims to be an end-to-end partner for drug developers, helping them navigate the journey from launch to long-term brand sustainability.

Integrated suite of commercial technology platforms (ACTICS, CONNECT, INTELLIGENCE) leveraging AI/ML, data analytics, and digital health tools to support pharmaceutical product launch, patient adherence, market access, and commercial operations.

Eversana competes in a fragmented market against large, diversified Contract Research Organizations (CROs) with commercial arms (e.g., IQVIA, Syneos Health), global consulting firms (e.g., Accenture, Deloitte), and smaller niche service providers. Its differentiation lies in its fully integrated, technology-first approach to end-to-end commercialization.